Tọrọ ntọala na 2009, JYMed bụ a ọgwụ enterprise na China na integrates R&D, nrụpụta, azụmahịa, na omenala mmepe na n'ichepụta nke peptide ngwaahịa. Companylọ ọrụ ahụ nwere ihe dị ka ndị ọrụ 570, yana ndị otu njikwa isi mejupụtara ndị ọkachamara nwere nka ọgwụ yana ahụmịhe karịrị afọ 20 na ụlọ ọrụ peptide. JYMed arụ ọrụ otu nnyocha center na abụọ isi mmepụta ụlọ ọrụ, ọbọ multi-ton ọnụ ọgụgụ mmepụta ikike na peptides, n'ọnọdu ya dị ka ụlọ ọrụ ndú.
Okwu mmalite nke JYMed, onye US FDA nyochara onye na-emepụta peptide. Ngwaahịa egosipụtara: peptide cosemtic, peptide APIs, peptides omenala, dị ka, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, wdg Iji matakwuo, biko kpọtụrụ
Email: jymed@jymedtech.com